0001104659-19-053357.txt : 20191008 0001104659-19-053357.hdr.sgml : 20191008 20191008142425 ACCESSION NUMBER: 0001104659-19-053357 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191008 DATE AS OF CHANGE: 20191008 EFFECTIVENESS DATE: 20191008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 191142517 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 09-30-2019 09-30-2019 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger (415) 801-8100 /s/ Robin L. Praeger San Francisco CA 10-07-2019 0 8 258454718 false INFORMATION TABLE 2 a19-19736_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 400290 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 2784014 543753 SH OTR 0 543753 0 Gritstone Oncology, Inc. Common Stock 39868T105 26793792 3102929 SH OTR 0 3102929 0 Second Sight Medical Products, Inc. Common Stock 81362J100 3706255 4492975 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 6734767 2215384 SH OTR 0 2215384 0 Audentes Therapeutics, Inc. Common Stock 05070R104 15559500 553916 SH OTR 0 553916 0 CRISPR Therapeutics AG Common Stock H17182108 173546331 4233870 SH OTR 0 4233870 0 Veracyte, Inc. Common Stock 92337F107 28929768 1205407 SH OTR 0 1205407 0